Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
WSAU Wausau· 1 week agoBy Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on...
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 2 days agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 weeks agovaccine was the third jab to be approved for use in the UK in January 2021 after the Pfizer/BioNTech...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 weeks agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 2 weeks agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Morningstar· 2 weeks agoBioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally ...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 4 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and ...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 2 days agoZimmerman, who believes her injury is due to a contaminated vaccine batch. The Covid vaccines, a...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 5 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...